Loading...
Loading...
A| Name | Value |
|---|---|
| Revenues | 1,668.0M |
| Cost of Revenue | 802.0M |
| Gross Profit | 866.0M |
| Operating Expense | 566.0M |
| Operating I/L | 300.0M |
| Other Income/Expense | -40.0M |
| Interest Income | 14.0M |
| Pretax | 260.0M |
| Income Tax Expense | 45.0M |
| Net Income/Loss | 215.0M |
Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets globally. The company's Life Sciences and Applied Markets segment offers a wide range of instruments and technologies for chromatography, mass spectrometry, spectroscopy, cell analysis, and laboratory automation. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, next-generation sequencing, and genetic data management. Additionally, Agilent CrossLab offers laboratory supplies, services, and support. The company generates revenue through direct sales, distributors, resellers, and electronic commerce.
